These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 7537468

  • 1. Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock.
    Altavilla D, Squadrito F, Canale P, Ioculano M, Campo GM, Squadrito G, Saitta A, Caputi AP.
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1412-7. PubMed ID: 7537468
    [Abstract] [Full Text] [Related]

  • 2. E-selectin involvement in the pathogenesis of splanchnic artery occlusion shock.
    Altavilla D, Squadrito F, Canale P, Ioculano M, Campo GM, Squadrito G, Ammendolia L, Caputi AP.
    Eur J Pharmacol; 1995 Jan 16; 272(2-3):223-9. PubMed ID: 7536163
    [Abstract] [Full Text] [Related]

  • 3. Contribution of intercellular adhesion molecule 1 (ICAM-1) to the pathogenesis of splanchnic artery occlusion shock in the rat.
    Squadrito F, Altavilla D, Canale P, Ioculano MP, Campo GM, Ammendolia L, Squadrito G, Saitta A, Calapai G, Caputi AP.
    Br J Pharmacol; 1994 Nov 16; 113(3):912-6. PubMed ID: 7858885
    [Abstract] [Full Text] [Related]

  • 4. Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Minutoli L, Ferlito M, Saitta A, Caputi AP.
    Eur J Pharmacol; 1998 Nov 13; 361(1):101-8. PubMed ID: 9851547
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Ferlito M, Campo GM, Arlotta M, Grimaldi S, Quartarone C, Saitta A, Caputi AP.
    Br J Pharmacol; 1999 May 13; 127(2):498-504. PubMed ID: 10385251
    [Abstract] [Full Text] [Related]

  • 6. Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Ioculano M, Calapai G, Zingarelli B, Saitta A, Campo GM, Rizzo A, Caputi AP.
    Circ Shock; 1992 Jul 13; 37(3):236-44. PubMed ID: 1423915
    [Abstract] [Full Text] [Related]

  • 7. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock.
    Squadrito F, Guarini S, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Cucinotta D, Bazzani C, Cainazzo MM, Mioni C, Bertolini A, Caputi AP.
    Br J Pharmacol; 1999 Oct 13; 128(3):816-22. PubMed ID: 10516667
    [Abstract] [Full Text] [Related]

  • 8. The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Ammedolia L, Arlotta M, Saitta A, Caputi AP.
    Br J Pharmacol; 1997 Jan 13; 120(2):333-9. PubMed ID: 9117128
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
    Squadrito F, Sturniolo R, Altavilla D, Santoro G, Campo GM, Arena A, Caputi AP.
    Eur J Pharmacol; 1991 Jan 03; 192(1):47-53. PubMed ID: 2040364
    [Abstract] [Full Text] [Related]

  • 14. Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock.
    Altavilla D, Guarini S, Bitto A, Mioni C, Giuliani D, Bigiani A, Squadrito G, Minutoli L, Venuti FS, Messineo F, De Meo V, Bazzani C, Squadrito F.
    Shock; 2006 May 03; 25(5):500-6. PubMed ID: 16680015
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P, Squadrito F, Altavilla D, Ioculano M, Campo GM, Squadrito G, Urna G, Sardella A, Caputi AP.
    Pharmacology; 1994 Dec 03; 49(6):376-85. PubMed ID: 7878075
    [Abstract] [Full Text] [Related]

  • 16. Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock.
    Cuzzocrea S, Nocentini G, Di Paola R, Mazzon E, Ronchetti S, Genovese T, Muià C, Caputi AP, Riccardi C.
    J Leukoc Biol; 2004 Nov 03; 76(5):933-40. PubMed ID: 15316036
    [Abstract] [Full Text] [Related]

  • 17. The involvement of tumour necrosis factor-alpha in the protective effects of 17 beta oestradiol in splanchnic ischaemia-reperfusion injury.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Arcoraci V, Minutoli L, Saitta A, Caputi AP.
    Br J Pharmacol; 1997 Aug 03; 121(8):1782-8. PubMed ID: 9283718
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock.
    Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muià C, Caputi AP.
    Shock; 2004 Oct 03; 22(4):340-6. PubMed ID: 15377889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.